Leonard S. Marks, MD

Leonard S. Marks, MD

David Geffen School of Medicine at UCLA

Los Angeles, California

Leonard S. Marks, MD, is a Professor of Urology at the David Geffen School of Medicine at UCLA. He graduated with honors (AOA) from the University of Texas, where he received both the MD and Masters of Arts (Physiology) degrees in 1969. He served an internship and residency in surgery at UCLA/Harbor General Hospital. He then served on active duty as Lieutenant Commander in the United States Public Health Service. He was later Research Fellow at Cedars/Sinai Medical Center and Post-Doctoral Research Scholar at UCLA School of Medicine. He completed his urology residency at UCLA and was Lecturer in Urology there in 1978, following which he entered private practice in Los Angeles. Dr. Marks was founder and medical director of Urological Sciences Research Foundation (USRF), a California non-profit organization (501c3), from its inception in 1992 through year-end 2008, when he joined the UCLA Department of Urology full-time. During that 17 year period, he led numerous studies on prostate diseases and men’s health and accumulated a publication list totaling more than 100 peer-reviewed articles. He maintains membership in local, state, and national medical associations, as well as the American Urological Association, the American Association of Clinical Urologists, and other professional societies.

Articles by Leonard S. Marks, MD

Focal Therapy of Prostate Cancer

Leonard S. Marks, MD, discusses the response propelling consideration of focal therapy as a treatment option for localized prostate cancer. He reviews evidence on the three currently-FDA approved focal therapy modalities: cryotherapy, high-intensity focused ultrasound (HIFU), and laser ablation.

Read More

MRI/US Fusion Biopsy

Leonard S. Marks, MD, reviews the utility of MR/US fusion prostate biopsy devices in detecting clinically significant prostate cancer and guiding targeted focal therapy. He also discusses how to develop a MR/US fusion biopsy procedure and integrate its use into a clinical practice.

Read More

Join the GRU Community

- Why Join? -